17-11679772-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001372.4(DNAH9):​c.3369T>C​(p.Asp1123Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.98 in 1,613,704 control chromosomes in the GnomAD database, including 776,019 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.97 ( 71261 hom., cov: 32)
Exomes 𝑓: 0.98 ( 704758 hom. )

Consequence

DNAH9
NM_001372.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.277

Publications

16 publications found
Variant links:
Genes affected
DNAH9 (HGNC:2953): (dynein axonemal heavy chain 9) This gene encodes the heavy chain subunit of axonemal dynein, a large multi-subunit molecular motor. Axonemal dynein attaches to microtubules and hydrolyzes ATP to mediate the movement of cilia and flagella. The gene expresses at least two transcript variants; additional variants have been described, but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
DNAH9 Gene-Disease associations (from GenCC):
  • ciliary dyskinesia, primary, 40
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • situs inversus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • schizophrenia
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 17-11679772-T-C is Benign according to our data. Variant chr17-11679772-T-C is described in ClinVar as Benign. ClinVar VariationId is 402776.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.277 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.982 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH9NM_001372.4 linkc.3369T>C p.Asp1123Asp synonymous_variant Exon 18 of 69 ENST00000262442.9 NP_001363.2 Q9NYC9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH9ENST00000262442.9 linkc.3369T>C p.Asp1123Asp synonymous_variant Exon 18 of 69 1 NM_001372.4 ENSP00000262442.3 Q9NYC9-1
DNAH9ENST00000454412.6 linkc.3369T>C p.Asp1123Asp synonymous_variant Exon 18 of 68 5 ENSP00000414874.2 E7EP17

Frequencies

GnomAD3 genomes
AF:
0.967
AC:
147142
AN:
152156
Hom.:
71210
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.929
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.971
Gnomad ASJ
AF:
0.969
Gnomad EAS
AF:
0.910
Gnomad SAS
AF:
0.963
Gnomad FIN
AF:
0.999
Gnomad MID
AF:
0.991
Gnomad NFE
AF:
0.988
Gnomad OTH
AF:
0.968
GnomAD2 exomes
AF:
0.972
AC:
244454
AN:
251422
AF XY:
0.974
show subpopulations
Gnomad AFR exome
AF:
0.928
Gnomad AMR exome
AF:
0.961
Gnomad ASJ exome
AF:
0.968
Gnomad EAS exome
AF:
0.912
Gnomad FIN exome
AF:
0.999
Gnomad NFE exome
AF:
0.989
Gnomad OTH exome
AF:
0.979
GnomAD4 exome
AF:
0.982
AC:
1434943
AN:
1461430
Hom.:
704758
Cov.:
40
AF XY:
0.982
AC XY:
713698
AN XY:
727070
show subpopulations
African (AFR)
AF:
0.929
AC:
31098
AN:
33468
American (AMR)
AF:
0.963
AC:
43047
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.968
AC:
25292
AN:
26130
East Asian (EAS)
AF:
0.906
AC:
35969
AN:
39692
South Asian (SAS)
AF:
0.966
AC:
83349
AN:
86242
European-Finnish (FIN)
AF:
0.999
AC:
53355
AN:
53414
Middle Eastern (MID)
AF:
0.979
AC:
5646
AN:
5768
European-Non Finnish (NFE)
AF:
0.988
AC:
1098277
AN:
1111618
Other (OTH)
AF:
0.976
AC:
58910
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
1262
2525
3787
5050
6312
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21656
43312
64968
86624
108280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.967
AC:
147253
AN:
152274
Hom.:
71261
Cov.:
32
AF XY:
0.968
AC XY:
72015
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.929
AC:
38586
AN:
41536
American (AMR)
AF:
0.971
AC:
14844
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.969
AC:
3366
AN:
3472
East Asian (EAS)
AF:
0.910
AC:
4708
AN:
5174
South Asian (SAS)
AF:
0.964
AC:
4645
AN:
4820
European-Finnish (FIN)
AF:
0.999
AC:
10607
AN:
10618
Middle Eastern (MID)
AF:
0.990
AC:
291
AN:
294
European-Non Finnish (NFE)
AF:
0.988
AC:
67252
AN:
68042
Other (OTH)
AF:
0.967
AC:
2042
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
241
483
724
966
1207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.980
Hom.:
98894
Bravo
AF:
0.962
Asia WGS
AF:
0.923
AC:
3211
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF -

Ciliary dyskinesia, primary, 40 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.32
DANN
Benign
0.25
PhyloP100
0.28
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8071438; hg19: chr17-11583089; COSMIC: COSV52334757; API